The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Mitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Polo-like kinases and the orchestration of cell division
Barr, F. A., Silljé, H. H. W., & Nigg, E. A. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1401 · Cited by 1,087
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Lane, H. A., & Nigg, E. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1701 · Cited by 690
Aurora-kinase inhibitors as anticancer agents
Keen, N., & Taylor, S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1502 · Cited by 675
The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1
Lénárt, P., Petronczki, M., Steegmaier, M., Di Fiore, B., Lipp, J. J., Hoffmann, M., Rettig, W. J., Kraut, N., & Peters, J.-M. (2007) · Current Biology · doi:10.1016/j.cub.2006.12.046 · Cited by 653
Self-citationPolo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
Liu, X., & Erikson, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031523100 · Cited by 472
Polo-like kinases (Plks) and cancer
Takai, N., Hamanaka, R., Yoshimatsu, J., & Miyakawa, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208272 · Cited by 386
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
Gumireddy, K., Reddy, M. V. R., Cosenza, S. C., Nathan, R. B., Baker, S. J., Papathi, N., Jiang, J., Holland, J., & Reddy, E. P. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.009 · Cited by 367
Roles of Polo-like Kinase 1 in the Assembly of Functional Mitotic Spindles
Sumara, I., Giménez-Abián, J. F., Gerlich, D., Hirota, T., Kraft, C., de la Torre, C., Ellenberg, J., & Peters, J.-M. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.049 · Cited by 345
Self-citationNormal Cells, but Not Cancer Cells, Survive Severe Plk1 Depletion
Liu, X., Lei, M., & Erikson, R. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2093-2108.2006 · Cited by 303
Polo-Like Kinases: A Team in Control of the Division
Weerdt, B. C. M. V. D., & Medema, R. H. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2692 · Cited by 300
Regulation of Sister Chromatid Cohesion between Chromosome Arms
Giménez-Abián, J. F., Sumara, I., Hirota, T., Hauf, S., Gerlich, D., de la Torre, C., Ellenberg, J., & Peters, J.-M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.052 · Cited by 229
Self-citationNear-infrared fluorescent imaging of tumor apoptosis.
Petrovsky, A., Schellenberger, E. A., Josephson, L., Weissleder, R., & Bogdanov, A. A., Jr. (2003) · PubMed · Cited by 204
van Vugt, M. A. T. M., van de Weerdt, B. C. M., Vader, G., Janssen, H., Calafat, J., Klompmaker, R., Wolthuis, R. M. F., & Medema, R. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313681200 · Cited by 198
Different Plk1 Functions Show Distinct Dependencies on Polo-Box Domain-mediated Targeting
Hanisch, A., Wehner, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0801 · Cited by 151
Probing cell-division phenotype space and Polo-like kinase function using small molecules
Peters, U., Cherian, J., Kim, J. H., Kwok, B. H. B., & Kapoor, T. M. (2006) · Nature Chemical Biology · doi:10.1038/nchembio826 · Cited by 125
Optical Imaging of Apoptosis as a Biomarker of Tumor Response to Chemotherapy
Schellenberger, E. A., Bogdanov, A. A., Jr., Petrovsky, A., Ntziachristos, V., Weissleder, R., & Josephson, L. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80050-7 · Cited by 123
Schuurmans, C. J., Motro, B., Yousefi, S., Heffernan, M. J., & Dennis, J. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6388 · Cited by 101
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance
McInnes, C., Mazumdar, A., Mezna, M., Meades, C. K., Midgley, C., Scaërou, F., Carpenter, L., Mackenzie, M., Taylor, P., Walkinshaw, M. D., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio825 · Cited by 99
Cited by
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6307 · Cited by 1,056
Self-citationTalele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Luo, J., Emanuele, M. J., Li, D., Creighton, C. J., Schlabach, M. R., Westbrook, T. F., Wong, K.-K., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.05.006 · Cited by 1,017
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Current prospects for RNA interference-based therapies
Davidson, B. L., & McCray, P. B. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2968 · Cited by 761
Metadata
- Authors
- Steegmaier, M., Hoffmann, M., Baum, A., Lénárt, P., Petronczki, M., Krššák, M., Gürtler, U., Garin-Chesa, P., Lieb, S., Quant, J., Grauert, M., Adolf, G. R., Kraut, N., Peters, J.-M., & Rettig, W. J.
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 17
- Issue
- 4
- Pages
- 316-322
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W2029108033
- Cited by
- 834
- References
- 21
- FWCI
- 15.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.